Next Article in Journal
Entamoeba histolytica Adaption to Auranofin: A Phenotypic and Multi-Omics Characterization
Previous Article in Journal
Angiotensin II Induces Oxidative Stress and Endothelial Dysfunction in Mouse Ophthalmic Arteries via Involvement of AT1 Receptors and NOX2
Previous Article in Special Issue
Amaranthus hypochondriacus L. as a Sustainable Source of Nutrients and Bioactive Compounds for Animal Feeding
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 10
Issue 8
10.3390/antiox10081239
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Curcumin Modulates Nitrosative Stress, Inflammation, and DNA Damage and Protects against Ochratoxin A-Induced Hepatotoxicity and Nephrotoxicity in Rats

by
Consiglia Longobardi
1,†,
Sara Damiano
2,*,†,
Emanuela Andretta
2,
Francesco Prisco
2,
Valeria Russo
2,
Francesco Pagnini
3,
Salvatore Florio
2 and
Roberto Ciarcia
2,*
1
Department of Mental, Physical Health and Preventive Medicine, University of Campania “Luigi Vanvitelli”, Naples, Largo Madonna delle Grazie 1, 80138 Napoli, Italy
2
Department of Veterinary Medicine and Animal Productions, University of Naples “Federico II”, Naples, Via Delpino 1, 80137 Napoli, Italy
3
Unit of Radiology, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy
*
Authors to whom correspondence should be addressed.
†
Equal contribution.
Antioxidants 2021, 10(8), 1239; https://doi.org/10.3390/antiox10081239
Submission received: 23 June 2021 / Revised: 27 July 2021 / Accepted: 31 July 2021 / Published: 2 August 2021
(This article belongs to the Special Issue Antioxidants in Veterinary Medicine)
Browse Figures
Versions Notes

Abstract

:
Ochratoxin A (OTA) is a fungal toxin of critical concern for food safety both for human health and several animal species, also representing a cancer threat to humans. Curcumin (CURC) is a natural polyphenol that has anti-apoptotic, anti-inflammatory, and antioxidant effects. The aim of this study was to investigate the cytoprotective effect of CURC against OTA-induced nephrotoxicity and hepatotoxicity through the study of the nitrosative stress, pro-inflammatory cytokines, and deoxyribonucleic acid (DNA) damage. Sprague Dawley rats were daily treated with CURC (100 mg/kg b.w.), OTA (0.5 mg/kg b.w), or CURC with OTA by oral gavage for 14 days. Our results demonstrated that OTA exposure was associated with significant increase of pro-inflammatory and DNA oxidative-damage biomarkers. Moreover, OTA induced the inducible nitric oxide synthase, (iNOS) resulting in increased nitric oxide (NO) levels both in kidney and liver. The co-treatment OTA + CURC counteracted the harmful effects of chronic OTA treatment by regulating inflammation, reducing NO levels and oxidative DNA damage in kidney and liver tissues. Histology revealed that OTA + CURC treatment determinates mainly an Iba1+ macrophagic infiltration with fewer CD3+ T-lymphocytes in the tissues. In conclusion, we evidenced that CURC exerted cytoprotective and antioxidant activities against OTA-induced toxicity in rats.

1. Introduction

Ochratoxin A (OTA) is a toxic secondary metabolite generated by several filamentous chlorophenolic fungal species belonging to Aspergillus and Penicillium genera [1,2]. Unfortunately, it is a food contaminant present in a large variety of agricultural products, including cereals, cereal-based products [3], grapes [4], herbs, coffee, cocoa, tea, fish, pork, milk and its products, poultry, and eggs [5,6]. Additionally, OTA is a danger both for people exposed to food diets containing OTA and animals. In these latter, OTA causes a greater morbidity and a diminution in production, negatively affecting the reproduction, nutrition, and growth of animals [7,8]. OTA is mostly hepatotoxic and nephrotoxic, but it also exhibited immunotoxic, carcinogenic, genotoxic, and possibly neurotoxic effects [9,10]. The International Agency for Research on Cancer (IARC) defined it as a possible carcinogen for humans (group 2B) [11]. The last European Food Safety Authority (EFSA) evaluation in 2006 and the international experts of the World Health Organization (WHO) stated that OTA may cause DNA damage by acting as a direct genotoxic carcinogen or through indirect mechanisms [12,13,14]. However, even though the exact molecular events involved in the DNA damage are not completely understood, both oxidative and nitrosative stress have been involved in these processes. In fact, it is hypothesized that OTA can induce overexpression of inducible nitric oxide synthase (iNOS), the enzyme responsible for producing nitric oxide (NO) [15]. NO plays a pivotal role as a redox-based signaling mediator, modulating enzyme activities, cytokine networks, and promoting reactive nitrogen species formation. In excess, NO in the kidney and liver may act as a toxic radical and causes an increase in nitrite and nitrate levels and in nitrosative stress, with protein and DNA damage as well as lipid peroxidation, necrosis, and apoptosis [16,17].
Curcumin (CURC), a natural polyphenolic compound extracted from the rhizomes of the turmeric plant (Curcuma longa) [18], has powerful antioxidant properties [19]. Since CURC can suppress genotoxic effects caused by radiation and various agents [20,21], one of the main objectives of the present work was to evaluate the beneficial effect of CURC on nitrosative stress and DNA damage in OTA-exposed rats. In our previous works, we demonstrated the efficacy of CURC on the kidney and liver of rats treated for 14 days with OTA as an antioxidant and powerful free-radical scavenger [22,23].
In addition, CURC is well known for its anti-inflammatory properties [19,20,21,22,23,24]. Indeed, CURC reduces the levels of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and the levels of pro-inflammatory cytokines, such as interleukin-1β (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) [25,26,27]. Since OTA increases inflammation [28,29], in this work, we also assessed whether CURC could mitigate inflammatory processes in kidney and liver of OTA-exposed rats.
A schematic illustration of working hypothesis of the present study is represented in Figure 1.
To understand the OTA-related negative consequences on animals and human health, it is firstly necessary to deepen the main mechanisms leading this mycotoxin to act. Since OTA primarily affects renal and hepatic tissues, we evaluated in this study the cytoprotective role of CURC against OTA-induced hepatic and renal toxicity.
The objective of the present work was to evidence for the first time the CURC cytoprotective action on OTA-induced toxicity in rats through the evaluation of the nitrosative stress, pro-inflammatory cytokines, and DNA damage, events that may be crucial in developing chronic OTA toxicity.

2. Materials and Methods

2.1. Chemicals

OTA and CURC were bought from Sigma-Aldrich (Milan, Italy) and 8-OHdG (8-hydroxy-2′-deoxyguanosine) ELISA kit from Stress Marq (Biosciences INC, Victoria, BC, Canada). Other chemicals and reagents used in this work were purchased from S.I.A.L s.r.l. (Rome, Italy). The animal supplier was Charles River Laboratories (Milan, Italy).

2.2. Ethic Statement

The experiment reported in this work shall abide by Italian and European law (National law: D.L. 26/2014; European law: Directive 2010/63/EU) and was approved by the Institutional Animal Care and Ethics Committee (Approval Number: 487/2018-PR).

2.3. Experimental Design

A total number of 24 Sprague Dawley rats (male, 250 to 270 g, 10 weeks old) were chosen for this study. All rats were randomly assigned (n = 6/group) to four groups and were maintained under environmentally controlled conditions (45–60% relative humidity, 22 ± 2 °C temperature; 12 h light–12 h dark cycle) and fed with a balanced commercial pellet (Teklad Global Diets) and tap water ad libitum. Rats were treated daily for 14 days by oral gavage as follows:
  • Control group: the rats received 2 mL/kg b.w. of olive oil;
  • OTA group: the rats received 0.5 mg/kg b.w. of OTA dissolved in 2 mL/kg b.w. of olive oil;
  • CURC group: the rats received 100 mg/kg b.w. of CURC dissolved in 2 mL/kg b.w. of olive oil;
  • OTA + CURC group: the rats received 2 mL/kg b.w. of olive oil containing 0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC.
Olive oil was used to achieve a greater stability of CURC. Both the duration of the experiment (14 days) and dosages of OTA and CURC were selected according to our previous data relating to their toxic chronic effects and antioxidant properties, respectively [30,31,32].

2.4. Samples Collection and Processing

After 2 weeks of daily treatment, animals were euthanized with 2% isoflurane (Isotec 4, Palermo, Italy), and after complete sedation, were sacrificed by cervical dislocation. Kidneys and liver of each rat were collected and washed with physiological saline 0.9%. To remove red blood cells and clots, the tissues were rinsed in 50 mmol/L of ice-cold sodium phosphate buffer saline (0.01 M, pH 7.4). Later, tissue samples were homogenized as follows: 1 g of the tissue for every 5–10 mL of ice-cold buffer solution, then centrifuged at 5000× g for 5 min. Then, the supernatants were kept at −80 °C for later evaluation of the content and activities of nitrosative stress and pro-inflammatory cytokines biomarkers in each tissue type. One-half of a kidney and a piece of liver were fixed in Bouin’s solution for histopathological and immunohistochemical analysis. Moreover, to measure oxidative DNA damage, 24-h urine was collected from the animals kept in metabolic cages. The results of lipid peroxidation and oxidative stress markers in kidneys and liver were reported in our previous papers [22,23], where CURC showed a good recovery of kidney and liver damage induced by OTA.

2.5. Pro-Inflammatory Cytokines Assay

Tumor necrosis factor-α (TNF-α), Nuclear factor-kappa B (NF-κB), interleukin-1β (IL-1β), and interleukin-6 (IL-6) levels in the hepatic and renal homogenates tissues were measured by commercial ELISA kits (Invitrogen, Waltham, MA, USA) following the manufacturer’s instruction. Optical densities (OD) obtained were read by ELISA Plate Reader (Glomax Multi detection system, Promega, Milan, Italy), the concentrations were expressed in nanograms per grams of tissue (ng/g tissue), and the measurements were conducted in triplicate.

2.6. Nitric Oxide Determination

NO was estimated spectrophotometrically in the hepatic and renal tissues with the Nitrite/Nitrate Assay Kit (Sigma-Aldrich, Milan, Italy) according to the manufacturer’s instructions. This method depends on the measurement of endogenous nitrite concentration as an indicator of NO production. It is based on the addition of Griess reagent, which converts nitrite into a deep purple azo compound, whose absorbance was read at 540 nm in a spectrophotometric multi-well plate reader (Glomax Multi detection system, Promega, Milan, Italy). The data were expressed as micromoles per gram of tissue (µmol/g tissue), and the measurements were conducted in triplicate.

2.7. iNOS Activity Assay

iNOS activities in liver and kidney tissues were determined by using a commercial ELISA kit (Sigma-Aldrich, Milan, Italy) in line with the manufacturer’s instructions. For this quantitative assay, we used the polyclonal iNOS rat specific antibody (Sigma-Aldrich, Milan, Italy) pre-coated onto microplates. Optical densities (OD) were read by ELISA Plate Reader (Glomax Multi detection system, Promega, Milan, Italy), and the results were expressed in nanogram per gram of tissue (ng/g tissue), and the measurements were conducted in triplicate.

2.8. 8-Hydroxy-2′-Deoxy Guanosine (8-OHdG) Analysis

Oxidative DNA damage was measured by the 8-OHdG ELISA kit from Stress Marq (Biosciences INC, Victoria, BC, Canada) in urine samples in accordance with the manufacturer’s protocol. Briefly, in a microtiter plate precoated with 8-OHdG, 50 μL of 8-OHdG standards (0.94–60 ng mL−1) and urine samples were separately plated in triplicates. Then, they were incubated with a specific HRP-conjugated antibody for 1 h. After the washing step, TMB substrate was incubated for 30 min. Then, the Stop solution provided by the kit reaction was used to stop the reaction. The absorbance at 450 nm was measured by spectrophotometer Glomax Multi Detection System (Promega, Madison, WI, USA). 8-OHdG urinary values were indicated as total amount excreted in 2 h, and the measurements were conducted in triplicate.

2.9. Hystopathological Examination

Twenty-four male Sprague Dawley rats (6 for group) were sacrificed, and their kidneys and livers were collected and fixed in Bouin’s solution for 24 h followed by trimming and routine paraffin wax embedding. Four-μm sections were used for hematoxylin and eosin staining, and three serial sections at 3 μm were stained for T-lymphocytes (CD3), B-lymphocytes (CD79), and macrophages (Iba1).

2.10. Immunoistochemistry Study

Immunohistochemistry was performed using our well-established method [33]. In detail, the liver and kidney paraffin sections at 3 μm were deparaffined in xylene and in decreasing series of alcohol. Peroxidases were blocked with a solution of hydrogen peroxide and methanol (4:1) for 15 min. The sections were incubated with a HIER citrate buffer pH 6.0 (Bio-Optica, Milan, Italy) for 20 min at 98 °C to perform antigen retrieval pretreatments. Subsequently, immunohistochemistry was carried out following the protocol suggested by the MACH1 Universal HRP-Polymer Detection Kit (Cat. No: M1U539 G, L10, Bio-Optica, Milan, Italy). The following primary antibodies were used: Polyclonal Rabbit Anti-CD3 (Code n. ab5690, Abcam, Cambridge, UK) at 1:100 in PBS, Monoclonal Mouse Anti-CD79 (Clone HM57, Dako, Santa Clara, CA, USA) at 1:100 in PBS, and Polyclonal Rabbit Anti-Iba1 (Code n. 019-19741, WAKO, Osaka, Japan) at 1:1000 in PBS [34]. Slides were examined and photographed with a light microscope (Nikon Eclipse E600 Tokyo, Japan) equipped with a microphotography system Nikon digital camera (DMX1200 Tokyo, Japan). A scoring system was designed to semi-quantitatively assess the degree of inflammation based on previously reported methods [35]. The number of inflammatory cells was scored by two independent pathologists (F.P. and V.R.) by light microscopy as: no infiltration (score 0); mild infiltration (score 1), on average 1 to 5 inflammatory cells per high-power field (HPF; 0.237 mm2; 40× objective and a 10× ocular with a field number of 22 mm); moderate infiltration (score 2), on average 6 to 10 inflammatory cells per HPF; and severe infiltration (score 3), on average more than 10 inflammatory cells per HPF. The average number was evaluated in at least 10 HPF for each sample.

2.11. Statistycal Analysis

The results on determination of pro-inflammatory cytokines activities were expressed as mean ± standard deviation (SD). Analysis of variance (ANOVA) tests followed by a Tukey’s test were used to analyze the differences (GraphPad Software 3.00, San Diego, CA, USA). Values of p < 0.05, p < 0.01, p < 0.001, and p < 0.0001 were considered statistically significant.

3. Results

3.1. Effect of CURC on Kidney and Hepatic Tissue Levels of NO

Figure 2 reports the results regarding renal and hepatic tissue levels of nitrite, stable products of the NO released in response to oxidative stress. The nitrite levels in kidney and liver were found significantly higher in OTA-treated group compared to the control group. However, co-administration with CURC significantly inhibited the increased production of nitrite in OTA group in both tissues. CURC-alone treatment did not exhibit a significant effect on nitrite release compared to the control group.

3.2. Effect of CURC on Liver and Kidney iNOS Activity

The hepatic and renal iNOS activity was significantly raised in OTA-treated group in comparison with the control group. However, co-administration with CURC significantly decreased the activities of hepatic and renal iNOS as compared to the OTA-treated group. CURC-alone treatment did not exhibit a significant effect on iNOS activity compared to the control group (Figure 3).

3.3. Effect of Curcumin on Pro-Inflammatory Cytokines Production in Kidney and Liver Tissues

In OTA-treated group compared to the control group, a significant increase of hepatic and renal NF-κB, TNF-α, IL-1β, and IL-6 levels was found. However, co-administration with CURC significantly modulated the values of renal and hepatic NF-κB, TNF-α, IL-1β, and IL-6 as compared to the OTA-treated group. There was no significant difference in the renal and hepatic NF-κB, TNF-α, IL-1β, and IL-6 levels between the control group and the CURC one (Figure 4, Figure 5, Figure 6 and Figure 7).

3.4. Effect of Curcumin on OTA-Induced DNA Damage

The 8-OHdG levels were measured in urine samples of control, OTA, CURC, and OTA + CURC groups. Urinary 8-OHdG levels were significantly higher in the OTA group with respect to the control group. CURC treatment in OTA group at the end of treatment significantly reduced urinary 8-OHdG levels when compared to the OTA group (Figure 8).

3.5. Histopayhological Examination

Inflammatory changes in the kidney of rats of both the OTA + CURC and OTA groups consisted of a multifocal interstitial inflammatory infiltrate, which occasionally invaded Bowman’s spaces and obscured the glomeruli. The inflammatory infiltrate was composed of mononuclear inflammatory cells. The liver of both the OTA + CURC and OTA group showed a multifocal interstitial inflammatory infiltrate often located in portal spaces and composed of mononuclear inflammatory cells. Only sparse infiltrating inflammatory cells were evident in the kidneys and liver of rats of the control and CURC groups (Figure 9). A semi-quantitative assessment of the morphological changes in both kidneys and liver were already reported in previously published papers [22,23] Here, we characterized the immunophenotype of the inflammatory cells. The inflammatory infiltrate is dominated by Iba1-positive macrophages associated with less CD3-positive T-lymphocytes and sparse CD79-positive B cells in both kidney and liver of rats belonging to the OTA + CURC and OTA groups (Figure 10 and Figure 11).

4. Discussion

OTA is a mycotoxin which causes serious health problems in both humans and animals, and we considered necessary in this work to investigate the main biochemical mechanisms of action underlying the toxic effects related to this mycotoxin. The primary target site for the action of OTA is the kidney [36] due to its slow elimination and vulnerability to oxidative damage caused by OTA-induced free radicals [37]. OTA also promotes inflammation, oxidative stress, or even cancer in the liver, which is the organ responsible for the processes of biotransformation of the mycotoxin [38]. The correlation between the impairment of oxidative balance and OTA-related toxicity is now in the public domain [9,10,39,40]. Therefore, the attention of the scientific community is directed towards the identification of natural antioxidant compounds with free-radical scavenging capacities to combat OTA-induced cytotoxicity. The purpose of this study was to assess if CURC, a natural polyphenol compound used as an herbal medicine for inflammatory diseases, had potential protective role on OTA-promoted nitrosative stress, DNA injury and, especially, inflammation in rat liver and kidney tissues. Our recent works [22,23] demonstrated the antioxidant effects of CURC on OTA-induced nephrotoxicity and hepatotoxicity in rats. In particular, while OTA caused oxidative stress, lipid peroxidation and reduced activity of the main antioxidant enzymes, CURC inhibited lipid peroxidation enhancing the activities of antioxidant enzymes in OTA-treated rats. Therefore, these data, in according with other findings present in the literature [41,42], demonstrated that CURC can be a good antioxidant and free-radical scavenger. The scavenging action of CURC against free radicals could be ascribed to the presence of methoxy and phenolic groups on the phenyl ring and 1,3-diketone [43], which make it capable of inhibiting lipid peroxidation. These mechanisms could explain at least in part the antioxidant effects of CURC. Starting from these data in this study, we investigated, for the first time, the cytoprotective and anti-inflammatory effect of CURC against OTA-induced toxicity in rats through the assessment of the nitrosative stress, pro-inflammatory cytokines, and oxidative DNA damage, processes that may result decisively in developing chronic toxicity connected to long-term exposure to OTA. Inflammatory processes and oxidative status impairment are both strongly linked to pathophysiological processes responsible for many chronic disorders, including liver and kidney diseases [44,45]. In fact, the altered oxidative balance can enhance chronic inflammation by the activation of different transcription factors, leading to inflammatory cytokines release. On the other hand, inflammation increases reactive nitrogen and oxygen species (RNS/ROS) levels, inducing further oxidation [46]. In this work, OTA treatment induced the overexpression of the inducible nitric oxide synthase (iNOS), causing a rise of NO levels in liver as well as in kidney and leading, in turn, to the nitrosative stress. NO is a pro-inflammatory mediator [47,48], and its overproduction can result in apoptosis and DNA or mitochondrial membrane damage [49]. The mechanism underlying NO oxidative toxicity may be dependent on the reaction between NO and superoxide radical to generate the pro-oxidant peroxynitrite, which is rapidly decomposed to the nitro radical, giving rise to nitrosative stress and DNA damage [50].
In particular, ROS and RNS promote DNA injury, developing 8-OHdG and 8-nitroguanosine and oxidative and nitrosative markers stress, respectively [51,52].
Since plasma is characterized by a huge complexity, urine represents a more used biological matrix to perform the evaluation of free 8-OHdG than plasma [53,54]. In the present work, we found an appreciable increase in 8-OHdG expression in urine of rats in the OTA-treated group. On the other hand, the co-treatment with CURC significantly reduced this 8-OHdG over-expression, exhibiting in this way the protective action of CURC against OTA-induced DNA damage.
Furthermore, OTA also increased the activity of NF-κB, in agreement with the data in the literature [15,17]. NF-κB regulates the immune response in many organs, playing a crucial role in various inflammatory diseases [55,56]. In fact, gene regulation and activation of proinflammatory cytokines, including IL-1β, TNF-α, IL-6, and iNOS, is controlled by NF-κB [57,58]. NF-κB dysregulation has been related to different pathological conditions, including cancer and several inflammatory diseases [59]. NF-κB signaling pathway could be activated or inactivated by different factors or stimulus signaling, such as TNF-α [60].
Moreover, TNF-α, a pro-inflammatory cytokine, represents a key mediator of inflammatory tissue damage [61,62]. Our results indicated the remarkable role of inflammatory processes in OTA-induced toxicity via NO, TNF-α, IL-6, and IL-1β elevations in renal and liver tissues of OTA-treated rats. The anti-inflammatory property of CURC observed in the rats simultaneously treated with OTA and CURC may be mediated through the ability of curcumin to suppress the pro-inflammatory cytokines TNF-α, IL-6, and IL-1β in renal and liver tissues. Ghosh et al. [63] suggested that the anti-inflammatory effects of curcumin are due to its ability to reduce TNF-α, IL-1, IL-6, COX-2, and NF-κB. CURC, with its ability to bind TNF-α directly, can inhibit both the production and activity of this cytokine [64]. As previously reported, histology confirmed the severity of inflammatory changes in both the kidney and liver of rats treated with OTA with respect to animals co-treated with both OTA and antioxidants such as CURC or anthocyanins [22,23,65]. In these tissues, the inflammatory infiltrate was characterized by the presence of mononuclear cells. Immunohistochemistry analysis evidenced that the infiltrate was dominated by Iba1+ macrophages with fewer CD3+ T-lymphocytes in OTA + CURC tissues. These findings are in agreement with the overexpression of the studied inflammatory mediators. Macrophages are a key population of innate immunity, and iNOS is a hallmark molecule of classical pathway-activated (M1) macrophages [66]. iNOS is highly expressed upon activation of the transcription factor NF-κB in response to many stimuli and regulates the differentiation and function of immune cells via nitration of key molecules involved in transcriptional or signaling pathways [66]. When activated, M1 macrophages express pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α [67]. IL-1β and TNF-α serve a critical role in leukocytes recruitment by promoting adhesion of leukocytes of the endothelium and their migration through blood vessels [68]. These cytokines are mainly released by activated macrophages and dendritic cells; however, TNF-α is also produced by T-lymphocytes and mast cells, and IL-1 is produced by endothelial cells as well [69,70]. IL-6 is a two-faced cytokine with both anti-inflammatory and pro-inflammatory activity depending on the tissue microenvironment [35]. IL-6 is produced by macrophages, lymphocytes, and endothelial cells, and in an inflammatory microenvironment together with other proinflammatory cytokines, including TNF-α, IL-6 promotes inflammation [35].
In conclusion, the biochemical data, confirmed by histopathological examinations, showed the cytoprotective action of CURC on the renal and hepatic rat tissues through the mitigation of OTA-induced inflammation, nitrosative stress and oxidative DNA damage.

Author Contributions

Conceptualization, S.D., S.F. and R.C.; methodology, S.D., C.L., E.A., F.P. (Francesco Prisco), F.P. (Francesco Pagnini), V.R., S.F. and R.C.; formal analysis, S.D., C.L., E.A., F.P. (Francesco Prisco), F.P. (Francesco Pagnini), V.R., S.F. and R.C.; writing—original draft preparation, S.D., C.L., S.F. and R.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines EU Directive 2010/63/EU and approved by the Institutional Animal Care and Ethics Committee (Approval Number: 487/2018-PR).

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets used and/or analyzed during the current study are not publicly available but are available from the corresponding authors on reasonable request.

Acknowledgments

Authors are grateful to Gianmarco Ferrara for his technical support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Samson, R.A.; Visagie, C.M.; Houbraken, J.; Hong, S.-B.; Hubka, V.; Klaassen, C.H.W.; Perrone, G.; Seifert, K.A.; Susca, A.; Tanney, J.B.; et al. Phylogeny, identification and nomenclature of the genus Aspergillus. Stud. Mycol. 2014, 78, 141–173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Pitt, J.I. Penicillium viridicatum, Penicillium verrucosum, and production of ochratoxin A. Appl. Environ. Microbiol. 1987, 53, 266–269. [Google Scholar] [CrossRef] [Green Version]
  3. Sun, X.D.; Su, P.; Shan, H. Mycotoxin Contamination of Maize in China. Compr. Rev. Food Sci. Food Saf. 2017, 16, 835–849. [Google Scholar] [CrossRef] [Green Version]
  4. Freire, L.; Passamani, F.R.F.; Thomas, A.B.; de Cássia Mirela Resende Nassur, R.; Silva, L.M.; Paschoal, F.N.; Pereira, G.E.; Prado, G.; Batista, L.R. Influence of physical and chemical characteristics of wine grapes on the incidence of Penicillium and Aspergillus fungi in grapes and ochratoxin A in wines. Int. J. Food Microbiol. 2017, 241, 181–190. [Google Scholar] [CrossRef] [Green Version]
  5. Iqbal, S.Z.; Nisar, S.; Asi, M.R.; Jinap, S. Natural incidence of aflatoxins, ochratoxin A and zearalenone in chicken meat and eggs. Food Control 2014, 43, 98–103. [Google Scholar] [CrossRef]
  6. Huong, B.T.M.; Tuyen, L.D.; Tuan, D.H.; Brimer, L.; Dalsgaard, A. Dietary exposure to aflatoxin B 1, ochratoxin A and fuminisins of adults in Lao Cai province, Viet Nam: A total dietary study approach. Food Chem. Toxicol 2016, 98, 127–133. [Google Scholar] [CrossRef]
  7. Bennett, J.W.; Klich, M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16, 497–516. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Diekman, M.A.; Green, M.L. Mycotoxins and reproduction in domestic livestock. J. Anim. Sci. 1992, 70, 1615–1627. [Google Scholar] [CrossRef] [Green Version]
  9. Costa, J.G.; Saraiva, N.; Guerreiro, P.S.; Louro, H.; Silva, M.J.; Miranda, J.P.; Castro, M.; Batinic-Haberle, I.; Fernandes, A.S.; Oliveira, N.G. Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: An integrative approach of complementary endpoints. Food Chem. Toxicol. 2016, 87, 65–76. [Google Scholar] [CrossRef]
  10. Tao, Y.; Xie, S.; Xu, F.; Liu, A.; Wang, Y.; Chen, D.; Pan, Y.; Huang, L.; Peng, D.; Wang, X.; et al. Ochratoxin A: Toxicity, oxidative stress and metabolism. Food Chem. Toxicol. 2018, 112, 320–331. [Google Scholar] [CrossRef]
  11. International Agency for Research on Cancer-IARC. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. In Monographs on the Evaluation of Carcinogenic Risks to Humans; World Health Organization: Lyon, France, 1993; ISBN 978-92-832-1256-0. [Google Scholar]
  12. Pfohl-Leszkowicz, A.; Manderville, R.A. An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity. Chem. Res. Toxicol. 2012, 25, 252–262. [Google Scholar] [CrossRef]
  13. Wangikar, P.B.; Dwivedi, P.; Sinha, N.; Sharma, A.K.; Telang, A.G. Teratogenic effects in rabbits of simultaneous exposure to ochratoxin A and aflatoxin B1 with special reference to microscopic effects. Toxicology 2005, 215, 37–47. [Google Scholar] [CrossRef] [PubMed]
  14. Gagliano, N.; Donne, I.D.; Torri, C.; Migliori, M.; Grizzi, F.; Milzani, A.; Filippi, C.; Annoni, G.; Colombo, P.; Costa, F.; et al. Early cytotoxic effects of ochratoxin A in rat liver: A morphological, biochemical and molecular study. Toxicology 2006, 225, 214–224. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Cavin, C.; Delatour, T.; Marin-Kuan, M.; Fenaille, F.; Holzhäuser, D.; Guignard, G.; Bezençon, C.; Piguet, D.; Parisod, V.; Richoz-Payot, J.; et al. Ochratoxin A-mediated DNA and protein damage: Roles of nitrosative and oxidative stresses. Toxicol. Sci. 2009, 110, 84–94. [Google Scholar] [CrossRef] [Green Version]
  16. Oldreive, C.; Rice-Evans, C. The mechanisms for nitration and nitrotyrosine formation in vitro and in vivo: Impact of diet. Free Radic. Res. 2001, 35, 215–231. [Google Scholar] [CrossRef]
  17. Sorrenti, V.; Di Giacomo, C.; Acquaviva, R.; Barbagallo, I.; Bognanno, M.; Galvano, F. Toxicity of Ochratoxin A and Its Modulation by Antioxidants: A Review. Toxins 2013, 5, 1742–1766. [Google Scholar] [CrossRef] [Green Version]
  18. Bagchi, A. Extraction of Curcumin. IOSR J. Environ. Sci. Toxicol. Food Technol. 2012, 1, 1–16. [Google Scholar] [CrossRef]
  19. Kuhad, A.; Pilkhwal, S.; Sharma, S.; Tirkey, N.; Chopra, K. Effect of Curcumin on Inflammation and Oxidative Stress in Cisplatin-Induced Experimental Nephrotoxicity. J. Agric. Food Chem. 2007, 55, 10150–10155. [Google Scholar] [CrossRef] [PubMed]
  20. Thresiamma, K.C.; George, J.; Kuttan, R. Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity. J. Exp. Clin. Cancer Res. 1998, 17, 431–434. [Google Scholar]
  21. Çelik, A.; Eke, D.; Ekinci, S.Y.; Yıldırım, S. The protective role of curcumin on perfluorooctane sulfonate-induced genotoxicity: Single cell gel electrophoresis and micronucleus test. Food Chem. Toxicol. 2013, 53, 249–255. [Google Scholar] [CrossRef]
  22. Damiano, S.; Longobardi, C.; Andretta, E.; Prisco, F.; Piegari, G.; Squillacioti, C.; Montagnaro, S.; Pagnini, F.; Badino, P.; Florio, S.; et al. Antioxidative Effects of Curcumin on the Hepatotoxicity Induced by Ochratoxin A in Rats. Antioxidants 2021, 10, 125. [Google Scholar] [CrossRef] [PubMed]
  23. Damiano, S.; Andretta, E.; Longobardi, C.; Prisco, F.; Paciello, O.; Squillacioti, C.; Mirabella, N.; Florio, S.; Ciarcia, R. Effects of curcumin on the renal toxicity induced by ochratoxin a in rats. Antioxidants 2020, 9, 332. [Google Scholar] [CrossRef] [Green Version]
  24. Strimpakos, A.S.; Sharma, R.A. Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials. Antioxid. Redox Signal. 2008, 10, 511–546. [Google Scholar] [CrossRef]
  25. Yin, H.; Guo, Q.; Li, X.; Tang, T.; Li, C.; Wang, H.; Sun, Y.; Feng, Q.; Ma, C.; Gao, C.; et al. Curcumin Suppresses IL-1β Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome. J. Immunol. 2018, 200, 2835–2846. [Google Scholar] [CrossRef] [Green Version]
  26. Tan, R.-Z.; Liu, J.; Zhang, Y.-Y.; Wang, H.-L.; Li, J.-C.; Liu, Y.-H.; Zhong, X.; Zhang, Y.-W.; Yan, Y.; Lan, H.-Y.; et al. Curcumin relieved cisplatin-induced kidney inflammation through inhibiting Mincle-maintained M1 macrophage phenotype. Phytomedicine 2019, 52, 284–294. [Google Scholar] [CrossRef] [PubMed]
  27. Sohn, S.-H.; Ko, E.; Chung, H.-S.; Lee, E.-Y.; Kim, S.-H.; Shin, M.; Hong, M.; Bae, H. The genome-wide expression profile of Curcuma longa-treated cisplatin-stimulated HEK293 cells. Br. J. Clin. Pharmacol. 2010, 70, 547–556. [Google Scholar] [CrossRef] [Green Version]
  28. Zhang, H.; Yan, A.; Liu, X.; Ma, Y.; Zhao, F.; Wang, M.; Loor, J.J.; Wang, H. Melatonin ameliorates ochratoxin A induced liver inflammation, oxidative stress and mitophagy in mice involving in intestinal microbiota and restoring the intestinal barrier function. J. Hazard. Mater. 2021, 407, 124489. [Google Scholar] [CrossRef]
  29. Le, G.; Yuan, X.; Hou, L.; Ge, L.; Liu, S.; Muhmood, A.; Liu, K.; Lin, Z.; Liu, D.; Gan, F.; et al. Ochratoxin A induces glomerular injury through activating the ERK/NF-κB signaling pathway. Food Chem. Toxicol. 2020, 143, 111516. [Google Scholar] [CrossRef] [PubMed]
  30. Damiano, S.; Navas, L.; Lombari, P.; Montagnaro, S.; Forte, I.M.; Giordano, A.; Florio, S.; Ciarcia, R. Effects of δ-tocotrienol on ochratoxin A-induced nephrotoxicity in rats. J. Cell. Physiol. 2018, 233, 8731–8739. [Google Scholar] [CrossRef]
  31. Damiano, S.; Puzio, M.V.; Squillacioti, C.; Mirabella, N.; Zona, E.; Mancini, A.; Borrelli, A.; Astarita, C.; Boffo, S.; Giordano, A.; et al. Effect of rMnSOD on Sodium Reabsorption in Renal Proximal Tubule in Ochratoxin A—Treated Rats. J. Cell. Biochem. 2018, 119, 424–430. [Google Scholar] [CrossRef] [PubMed]
  32. Ciarcia, R.; Damiano, S.; Squillacioti, C.; Mirabella, N.; Pagnini, U.; Florio, A.; Severino, L.; Capasso, G.; Borrelli, A.; Mancini, A.; et al. Recombinant Mitochondrial Manganese Containing Superoxide Dismutase Protects Against Ochratoxin A-Induced Nephrotoxicity. J. Cell. Biochem. 2016, 117, 1352–1358. [Google Scholar] [CrossRef] [Green Version]
  33. Pagano, T.B.; Prisco, F.; de Biase, D.; Piegari, G.; Maurelli, M.P.; Rinaldi, L.; Cringoli, G.; Papparella, S.; Paciello, O. Muscular Sarcocystosis in Sheep Associated With Lymphoplasmacytic Myositis and Expression of Major Histocompatibility Complex Class I and II. Vet. Pathol. 2020, 57, 272–280. [Google Scholar] [CrossRef] [PubMed]
  34. Rapa, S.F.; Prisco, F.; Popolo, A.; Iovane, V.; Autore, G.; di Iorio, B.R.; Dal Piaz, F.; Paciello, O.; Nishijima, F.; Marzocco, S. Pro-Inflammatory Effects of Indoxyl Sulfate in Mice: Impairment of Intestinal Homeostasis and Immune Response. Int. J. Mol. Sci. 2021, 22, 1135. [Google Scholar] [CrossRef]
  35. Prisco, F.; de Biase, D.; Piegari, G.; D’Aquino, I.; Lama, A.; Comella, F.; Mercogliano, R.; Dipineto, L.; Papparella, S.; Paciello, O. Pathologic characterization of white striping myopathy in broiler chickens. Poult. Sci. 2021, 100, 101150. [Google Scholar] [CrossRef]
  36. Gekle, M.; Sauvant, C.; Schwerdt, G. Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells. Mol. Nutr. Food Res. 2005, 49, 118–130. [Google Scholar] [CrossRef] [PubMed]
  37. Luhe, A.; Hildebrand, H.; Bach, U.; Dingermann, T.; Ahr, H.-J. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: Expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 2003, 73, 315–328. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, W.; Zhai, S.; Xia, Y.; Wang, H.; Ruan, D.; Zhou, T.; Zhu, Y.; Zhang, H.; Zhang, M.; Ye, H.; et al. Ochratoxin A induces liver inflammation: Involvement of intestinal microbiota. Microbiome 2019, 7, 151. [Google Scholar] [CrossRef] [PubMed]
  39. Malir, F.; Ostry, V.; Pfohl-Leszkowicz, A.; Malir, J.; Toman, J. Ochratoxin A: 50 Years of Research. Toxins 2016, 8, 191. [Google Scholar] [CrossRef] [Green Version]
  40. Palabiyik, S.S.; Erkekoglu, P.; Zeybek, N.D.; Kızılgun, M.; Sahin, G.; Giray, B.K. Ochratoxin A causes oxidative stress and cell death in rat liver. World Mycotoxin J. 2012, 5, 377–384. [Google Scholar] [CrossRef]
  41. Ak, T.; Gülçin, I. Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 2008. [Google Scholar] [CrossRef]
  42. Somparn, P.; Phisalaphong, C.; Nakornchai, S.; Unchern, S.; Morales, N.P. Comparative Antioxidant Activities of Curcumin and Its Demethoxy and Hydrogenated Derivatives. Biol. Pharm. Bull. 2007, 30, 74–78. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Priyadarsini, K.I.; Maity, D.K.; Naik, G.H.; Kumar, M.S.; Unnikrishnan, M.K.; Satav, J.G.; Mohan, H. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med. 2003, 35, 475–484. [Google Scholar] [CrossRef]
  44. Ambade, A.; Mandrekar, P. Oxidative Stress and Inflammation: Essential Partners in Alcoholic Liver Disease. Int. J. Hepatol. 2012, 2012, 1–9. [Google Scholar] [CrossRef]
  45. Cachofeiro, V.; Goicochea, M.; de Vinuesa, S.G.; Oubiña, P.; Lahera, V.; Luño, J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int. 2008, 74, S4–S9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Forstermann, U.; Sessa, W.C. Nitric oxide synthases: Regulation and function. Eur. Heart J. 2012, 33, 829–837. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Sharma, J.N.; Al-Omran, A.; Parvathy, S.S. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007, 15, 252–259. [Google Scholar] [CrossRef]
  48. Vitiello, M.; D’Isanto, M.; Finamore, E.; Ciarcia, R.; Kampanaraki, A.; Galdiero, M. Role of mitogen-activated protein kinases in the iNOS production and cytokine secretion by Salmonella enterica serovar Typhimurium porins. Cytokine 2008. [Google Scholar] [CrossRef] [PubMed]
  49. Ozkan, G.; Ulusoy, S.; Orem, A.; Alkanat, M.; Mungan, S.; Yulug, E.; Yucesan, F.B. How Does Colistin-Induced Nephropathy Develop and Can It Be Treated? Antimicrob. Agents Chemother. 2013, 57, 3463–3469. [Google Scholar] [CrossRef] [Green Version]
  50. Korhonen, R.; Lahti, A.; Kankaanranta, H.; Moilanen, E. Nitric Oxide Production and Signaling in Inflammation. Curr. Drug Target. Inflamm. Allergy 2005, 4, 471–479. [Google Scholar] [CrossRef]
  51. Valavanidis, A.; Vlachogianni, T.; Fiotakis, C. 8-hydroxy-2’ -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health. C Environ. Carcinog. Ecotoxicol. Rev. 2009, 27, 120–139. [Google Scholar] [CrossRef] [Green Version]
  52. Masuda, M.; Nishino, H.; Ohshima, H. Formation of 8-nitroguanosine in cellular RNA as a biomarker of exposure to reactive nitrogen species. Chem. Biol. Interact. 2002, 139, 187–197. [Google Scholar] [CrossRef]
  53. Loft, S.; Danielsen, P.; Løhr, M.; Jantzen, K.; Hemmingsen, J.G.; Roursgaard, M.; Karotki, D.G.; Møller, P. Urinary excretion of 8-oxo-7,8-dihydroguanine as biomarker of oxidative damage to DNA. Arch. Biochem. Biophys. 2012, 518, 142–150. [Google Scholar] [CrossRef] [PubMed]
  54. Poulsen, H.E.; Weimann, A.; Henriksen, T.; Kjær, L.K.; Larsen, E.L.; Carlsson, E.R.; Christensen, C.K.; Brandslund, I.; Fenger, M. Oxidatively generated modifications to nucleic acids in vivo: Measurement in urine and plasma. Free Radic. Biol. Med. 2019, 145, 336–341. [Google Scholar] [CrossRef]
  55. Mantawy, E.M.; El-Bakly, W.M.; Esmat, A.; Badr, A.M.; El-Demerdash, E. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Eur. J. Pharmacol. 2014, 728, 107–118. [Google Scholar] [CrossRef] [PubMed]
  56. Farombi, E.O.; Shrotriya, S.; Surh, Y.-J. Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-κB and AP-1. Life Sci. 2009, 84, 149–155. [Google Scholar] [CrossRef] [PubMed]
  57. Nafees, S.; Rashid, S.; Ali, N.; Hasan, S.K.; Sultana, S. Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: Role of NFκB/MAPK pathway. Chem. Biol. Interact. 2015, 231, 98–107. [Google Scholar] [CrossRef]
  58. Kandemir, F.M.; Kucukler, S.; Caglayan, C.; Gur, C.; Batil, A.A.; Gülçin, İ. Therapeutic effects of silymarin and naringin on methotrexate-induced nephrotoxicity in rats: Biochemical evaluation of anti-inflammatory, antiapoptotic, and antiautophagic properties. J. Food Biochem. 2017, 41, e12398. [Google Scholar] [CrossRef]
  59. Moon, D.-O.; Kim, M.-O.; Kang, S.-H.; Choi, Y.H.; Kim, G.-Y. Sulforaphane suppresses TNF-α-mediated activation of NF-κB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Cancer Lett. 2009, 274, 132–142. [Google Scholar] [CrossRef] [PubMed]
  60. Hoesel, B.; Schmid, J.A. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 2013, 12, 86. [Google Scholar] [CrossRef] [Green Version]
  61. Vielhauer, V.; Mayadas, T.N. Functions of TNF and its Receptors in Renal Disease: Distinct Roles in Inflammatory Tissue Injury and Immune Regulation. Semin. Nephrol. 2007, 27, 286–308. [Google Scholar] [CrossRef]
  62. Parameswaran, N.; Patial, S. Tumor necrosis factor-α signaling in macrophages. Crit Rev. Eukaryot Gene Expr. 2010, 20, 87–103. [Google Scholar] [CrossRef] [PubMed]
  63. Ghosh, S.; Banerjee, S.; Sil, P.C. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem. Toxicol. 2015, 83, 111–124. [Google Scholar] [CrossRef]
  64. Aggarwal, B.B.; Gupta, S.C.; Sung, B. Curcumin: An orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br. J. Pharmacol. 2013, 169, 1672–1692. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Damiano, S.; Iovane, V.; Squillacioti, C.; Mirabella, N.; Prisco, F.; Ariano, A.; Amenta, M.; Giordano, A.; Florio, S.; Ciarcia, R. Red orange and lemon extract prevents the renal toxicity induced by ochratoxin A in rats. J. Cell. Physiol. 2020, 235, 5386–5393. [Google Scholar] [CrossRef]
  66. Xue, Q.; Yan, Y.; Zhang, R.; Xiong, H. Regulation of iNOS on Immune Cells and Its Role in Diseases. Int. J. Mol. Sci. 2018, 19, 3805. [Google Scholar] [CrossRef] [Green Version]
  67. Zhang, C.; Yang, M.; Ericsson, A.C. Function of Macrophages in Disease: Current Understanding on Molecular Mechanisms. Front. Immunol. 2021, 12, 620510. [Google Scholar] [CrossRef]
  68. Malbon, A.J.; Meli, M.L.; Barker, E.N.; Davidson, A.D.; Tasker, S.; Kipar, A. Inflammatory Mediators in the Mesenteric Lymph Nodes, Site of a Possible Intermediate Phase in the Immune Response to Feline Coronavirus and the Pathogenesis of Feline Infectious Peritonitis? J. Comp. Pathol. 2019, 166, 69–86. [Google Scholar] [CrossRef]
  69. Turner, M.D.; Nedjai, B.; Hurst, T.; Pennington, D.J. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim. Biophys. Acta 2014, 1843, 2563–2582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Arend, W.P. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: The role of interleukin-1 receptor antagonist. Semin. Arthritis Rheum. 2001, 30, 1–6. [Google Scholar] [CrossRef]
Antioxidants 10 01239 g001 550
Figure 1. Schematic illustration of the working hypothesis of the present study.
Figure 1. Schematic illustration of the working hypothesis of the present study.
Antioxidants 10 01239 g001
Antioxidants 10 01239 g002 550
Figure 2. The antioxidant effect of curcumin (CURC) on the nitric oxide (NO) levels in the kidney and liver of different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n= 6 rats (**** p < 0.0001 vs. control; ### p < 0.001 and #### p < 0.0001 vs. OTA).
Figure 2. The antioxidant effect of curcumin (CURC) on the nitric oxide (NO) levels in the kidney and liver of different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n= 6 rats (**** p < 0.0001 vs. control; ### p < 0.001 and #### p < 0.0001 vs. OTA).
Antioxidants 10 01239 g002
Antioxidants 10 01239 g003 550
Figure 3. The antioxidant effect of curcumin (CURC) on kidney and liver inducible nitric oxide synthase (iNOS) activity in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group (**** p < 0.0001 vs. Control; #### p < 0.0001 vs. OTA).
Figure 3. The antioxidant effect of curcumin (CURC) on kidney and liver inducible nitric oxide synthase (iNOS) activity in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group (**** p < 0.0001 vs. Control; #### p < 0.0001 vs. OTA).
Antioxidants 10 01239 g003
Antioxidants 10 01239 g004 550
Figure 4. Effect of curcumin (CURC) on kidney and liver nuclear factor-kappa B (NF–kB) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n= 6 rats in each group (*** p < 0.001 and **** p <0.0001 vs. control; ## p < 0.01 and #### p < 0.0001 vs. OTA).
Figure 4. Effect of curcumin (CURC) on kidney and liver nuclear factor-kappa B (NF–kB) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n= 6 rats in each group (*** p < 0.001 and **** p <0.0001 vs. control; ## p < 0.01 and #### p < 0.0001 vs. OTA).
Antioxidants 10 01239 g004
Antioxidants 10 01239 g005 550
Figure 5. Effect of curcumin (CURC) on kidney and liver tumor necrosis factor-α (TNF-α) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group (**** p < 0.0001 vs. control; #### p < 0.0001 vs. OTA).
Figure 5. Effect of curcumin (CURC) on kidney and liver tumor necrosis factor-α (TNF-α) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group (**** p < 0.0001 vs. control; #### p < 0.0001 vs. OTA).
Antioxidants 10 01239 g005
Antioxidants 10 01239 g006 550
Figure 6. Effect of curcumin (CURC) on kidney and liver interleukin-1β (IL-1β) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group (**** p < 0.0001 vs. control; #### p < 0.0001 vs. OTA).
Figure 6. Effect of curcumin (CURC) on kidney and liver interleukin-1β (IL-1β) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group (**** p < 0.0001 vs. control; #### p < 0.0001 vs. OTA).
Antioxidants 10 01239 g006
Antioxidants 10 01239 g007 550
Figure 7. Effect of curcumin (CURC) on kidney and liver interleukin-6 (IL-6) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group. (*** p < 0.001 and **** p < 0.0001 vs. control; # p < 0.05 and ## p < 0.01 vs. OTA).
Figure 7. Effect of curcumin (CURC) on kidney and liver interleukin-6 (IL-6) level in different experimental groups after 14 days of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are expressed as mean ± standard deviation (SD) of n = 6 rats in each group. (*** p < 0.001 and **** p < 0.0001 vs. control; # p < 0.05 and ## p < 0.01 vs. OTA).
Antioxidants 10 01239 g007
Antioxidants 10 01239 g008 550
Figure 8. Effect of curcumin (CURC) on urinary 8-OHdG concentration at the end of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are shown as mean ± standard deviation (DS) (n = 6 for each group) and were compared by ANOVA (**** p <0.0001 vs. control, #### p < 0.0001 vs. OTA).
Figure 8. Effect of curcumin (CURC) on urinary 8-OHdG concentration at the end of treatment. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Data are shown as mean ± standard deviation (DS) (n = 6 for each group) and were compared by ANOVA (**** p <0.0001 vs. control, #### p < 0.0001 vs. OTA).
Antioxidants 10 01239 g008
Antioxidants 10 01239 g009 550
Figure 9. Histological examination of kidneys and liver of rats. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Hematoxylin and Eosin stain, 40× magnification, scale bar = 100 µm. Arrowheads indicate the infiltrating inflammatory cells.
Figure 9. Histological examination of kidneys and liver of rats. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Hematoxylin and Eosin stain, 40× magnification, scale bar = 100 µm. Arrowheads indicate the infiltrating inflammatory cells.
Antioxidants 10 01239 g009
Antioxidants 10 01239 g010 550
Figure 10. Immunohistochemical characterization of the inflammatory infiltrates in kidney (A) and liver (B) of rats. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Immunohistochemistry, 40× magnification, scale bar = 100 µm. Arrowheads indicate positive cells.
Figure 10. Immunohistochemical characterization of the inflammatory infiltrates in kidney (A) and liver (B) of rats. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Immunohistochemistry, 40× magnification, scale bar = 100 µm. Arrowheads indicate positive cells.
Antioxidants 10 01239 g010
Antioxidants 10 01239 g011 550
Figure 11. Semi-quantitative assessment of the inflammatory infiltrates in kidneys (A) and liver (B) of rats. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Iba1 antigen has been used to stain macrophages, CD3 antigen for T-lymphocyte, and CD79 antigen for B-lymphocyte (* p < 0.05 vs. control).
Figure 11. Semi-quantitative assessment of the inflammatory infiltrates in kidneys (A) and liver (B) of rats. Control group; CURC group (100 mg/kg b.w. of CURC); OTA group (0.5 mg/kg b.w. of OTA); OTA + CURC group (0.5 mg/kg b.w. of OTA plus 100 mg/kg b.w. of CURC). Iba1 antigen has been used to stain macrophages, CD3 antigen for T-lymphocyte, and CD79 antigen for B-lymphocyte (* p < 0.05 vs. control).
Antioxidants 10 01239 g011
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Longobardi, C.; Damiano, S.; Andretta, E.; Prisco, F.; Russo, V.; Pagnini, F.; Florio, S.; Ciarcia, R. Curcumin Modulates Nitrosative Stress, Inflammation, and DNA Damage and Protects against Ochratoxin A-Induced Hepatotoxicity and Nephrotoxicity in Rats. Antioxidants 2021, 10, 1239. https://doi.org/10.3390/antiox10081239

AMA Style

Longobardi C, Damiano S, Andretta E, Prisco F, Russo V, Pagnini F, Florio S, Ciarcia R. Curcumin Modulates Nitrosative Stress, Inflammation, and DNA Damage and Protects against Ochratoxin A-Induced Hepatotoxicity and Nephrotoxicity in Rats. Antioxidants. 2021; 10(8):1239. https://doi.org/10.3390/antiox10081239

Chicago/Turabian Style

Longobardi, Consiglia, Sara Damiano, Emanuela Andretta, Francesco Prisco, Valeria Russo, Francesco Pagnini, Salvatore Florio, and Roberto Ciarcia. 2021. "Curcumin Modulates Nitrosative Stress, Inflammation, and DNA Damage and Protects against Ochratoxin A-Induced Hepatotoxicity and Nephrotoxicity in Rats" Antioxidants 10, no. 8: 1239. https://doi.org/10.3390/antiox10081239

APA Style

Longobardi, C., Damiano, S., Andretta, E., Prisco, F., Russo, V., Pagnini, F., Florio, S., & Ciarcia, R. (2021). Curcumin Modulates Nitrosative Stress, Inflammation, and DNA Damage and Protects against Ochratoxin A-Induced Hepatotoxicity and Nephrotoxicity in Rats. Antioxidants, 10(8), 1239. https://doi.org/10.3390/antiox10081239

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop